Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways

被引:115
|
作者
Taylor, C [1 ]
Fricker, AD [1 ]
Devi, LA [1 ]
Gomes, N [1 ]
机构
[1] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
关键词
anxiety; depression; neurogenesis; SSRI; CRH; cortisol;
D O I
10.1016/j.cellsig.2004.12.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antidepressants are commonly used in the treatment of anxiety and depression, medical conditions that affect similar to17-20% of the population. The clinical effects of antidepressants take several weeks to manifest, suggesting that these drugs induce adaptive changes in brain structures affected by anxiety and depression. In order to develop shorter-acting and more effective drugs for the treatment of anxiety and depression, it is important to understand how antidepressants bring about their beneficial effects. Recent reports suggest that antidepressants can induce neurogenesis in the adult brain, although the mechanisms involved are not clearly understood. In this review, we describe the different neurotransmitter systems that are affected by anxiety and depression and how they are modulated by antidepressant treatment with a focus on signaling molecules and pathways that are activated during neurotransmitter receptor induced neurogenesis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:549 / 557
页数:9
相关论文
共 50 条
  • [31] Antidepressants as analgesics: an overview of central and peripheral mechanisms of action
    Sawynok, J
    Esser, MJ
    Reid, AR
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2001, 26 (01): : 21 - 29
  • [32] Antidepressants: will new mechanisms of action improve poor outcomes?
    Palaniyappan, Lena
    McAllister-Williams, R. Hamish
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (02) : 88 - 90
  • [33] Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs
    Wang, Man
    Jiang, Shuai
    Zhou, Li
    Yu, Fei
    Ding, Han
    Li, Peifeng
    Zhou, Meng
    Wang, Kun
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (06): : 1200 - 1214
  • [34] ANTIPSYCHOTIC DRUG MECHANISMS AND NEUROTRANSMITTER SYSTEMS IN SCHIZOPHRENIA
    REYNOLDS, GP
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 : 36 - 40
  • [35] NEUROTRANSMITTER SYSTEMS IN NEUROIMMUNOMODULATION - EXTRAIMMUNE AND INTRAIMMUNE MECHANISMS
    DEVOINO, L
    FASEB JOURNAL, 1995, 9 (03): : A506 - A506
  • [36] Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action
    Stahl, SM
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 : 5 - 14
  • [37] Levetiracetam Mechanisms of Action: From Molecules to Systems
    Jatziri Contreras-Garcia, Itzel
    Cardenas-Rodriguez, Noemi
    Romo-Mancillas, Antonio
    Bandala, Cindy
    Zamudio, Sergio R.
    Gomez-Manzo, Saul
    Hernandez-Ochoa, Beatriz
    Griselda Mendoza-Torreblanca, Julieta
    Adriana Pichardo-Macias, Luz
    PHARMACEUTICALS, 2022, 15 (04)
  • [38] Signaling pathways for the Biosynthesis and action of Jasmonates
    Jong-Joo Cheong
    Yang Do Choi
    Journal of Plant Biology, 2007, 50 : 122 - 131
  • [39] Signaling pathways for the biosynthesis and action of jasmonates
    Cheong, Jong-Joo
    Choi, Yang Do
    JOURNAL OF PLANT BIOLOGY, 2007, 50 (02) : 122 - 131
  • [40] MODULATION OF MEMBRANE FLUIDITY AND MECHANISMS OF NEUROTRANSMITTER ACTION DURING AGING
    SAMUEL, D
    GERONTOLOGIST, 1982, 22 : 51 - 52